Reporting Quality of Abstracts in Phase III Clinical Trials of Systemic Therapy in Metastatic Solid Malignancies

Trials - United Kingdom
doi 10.1186/s13063-015-0885-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Methodological Quality and Reporting of Ethical Requirements in Phase III Cancer Trials

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2005English

Reporting Quality-Of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation

American Journal of Kidney Diseases
Nephrology
2016English

Quality of Life Reporting in Multiple Sclerosis Clinical Trials: Enough Quality?

Multiple Sclerosis
Neurology
2012English

Quality of Reporting in Randomized Trials

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2010English

Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Dose Modifications in Adjuvant Chemotherapy for Solid Organ Malignancies: A Systematic Review of Clinical Trials

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Reporting of Clinical Trials in Gut: The CONSORT Statement. Consolidated Standards of Reporting Trials.

Gut
Gastroenterology
1997English

Catalogue of Errors in Papers Reporting Clinical Trials

British Medical Journal
Medicine
2015English

Assessment of the Quality of Reporting in Abstracts of Randomized Controlled Trials Published in Five Leading Chinese Medical Journals

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy